NCT07203287View on ClinicalTrials.gov

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

September 26, 2025

Study Completion Date

August 26, 2027

Conditions
Post Operative Pulmonary ComplicationsNeuromuscular BlockadeGeneral Anesthesia
Interventions
DRUG

Rocuronium

Will be assessing neuromuscular blockade with rocuronium and reversal with sugammadex

DRUG

Cisatracurium

Will be assessing neuromuscular blockade with neostigmine and reversal with neostigmine

Trial Locations (1)

77554

RECRUITING

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER